Valuation: Chugai Pharmaceutical Co., Ltd.

Market Cap 11,407B 71.57B 62.04B 58.16B 53.03B 99.78B 6,831B 101B 685B 267B 3,419B 269B 263B P/E 2026 *
22.5x
P/E 2027 * 19.3x
Enterprise Value 10,497B 65.86B 57.09B 53.52B 48.8B 91.82B 6,286B 93.29B 630B 246B 3,147B 247B 242B EV / Sales 2026 *
7.55x
EV / Sales 2027 * 6.66x
Free-Float
38.12%
Yield 2026 *
1.96%
Yield 2027 * 2.24%
1 day+2.59%
1 week+12.88%
Current month+9.90%
1 month+6.31%
3 months-3.73%
6 months-22.08%
Current year-9.59%
1 week 21.86
Extreme 21.86
23.93
1 month 20.58
Extreme 20.58
23.93
Current year 20.58
Extreme 20.58
34.84
1 year 20.27
Extreme 20.27
34.84
3 years 13.85
Extreme 13.85
34.84
5 years 10.99
Extreme 10.99
34.84
10 years 4.49
Extreme 4.4875
100
Manager TitleAgeSince
Chief Executive Officer 63 2021-02-28
Director of Finance/CFO 59 2024-03-27
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 63 2020-02-29
Director/Board Member 59 2024-03-27
Director/Board Member 51 2025-02-28
Change 5-day change 1-year change 3-year change Capi.($)
+2.59%+12.88% - - 74.07B
-1.91%-0.09%+73.08%+120.19% 1,078B
-0.77%+0.19%+48.65%+49.75% 632B
-0.73%+0.89%+21.28%+63.03% 443B
-1.95%-3.38%+41.90%+34.00% 356B
-1.23%-3.29%+23.61%+34.01% 289B
-2.11%-3.74%-1.17%+3.03% 245B
-1.45%+0.23%+41.89%+57.84% 226B
-1.19%-3.21%-9.00%-52.32% 204B
-0.49%+2.99%+15.27%+71.81% 171B
Average -0.94%+1.43%+28.39%+42.37% 404.85B
Weighted average by Cap. -1.33%+1.30%+41.34%+62.10%

Financials

2026 *2027 *
Net sales 1,390B 8.72B 7.56B 7.09B 6.46B 12.16B 832B 12.35B 83.45B 32.58B 417B 32.75B 32.04B 1,539B 9.66B 8.37B 7.85B 7.15B 13.46B 921B 13.68B 92.38B 36.06B 461B 36.25B 35.46B
Net income 507B 3.18B 2.76B 2.59B 2.36B 4.44B 304B 4.51B 30.46B 11.89B 152B 11.95B 11.69B 591B 3.71B 3.21B 3.01B 2.75B 5.17B 354B 5.25B 35.48B 13.85B 177B 13.92B 13.62B
Net Debt -910B -5.71B -4.95B -4.64B -4.23B -7.96B -545B -8.09B -54.64B -21.33B -273B -21.44B -20.98B -1,152B -7.23B -6.27B -5.87B -5.36B -10.08B -690B -10.24B -69.15B -27B -345B -27.14B -26.55B
Logo Chugai Pharmaceutical Co., Ltd.
Chugai Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the research, development, manufacture, sale, import and export of pharmaceutical products. The pharmaceutical products and medical devices for patients include ACTEMRA, Avastin, ALAGLIO, Aresensa, Kadosaira, Gazaiba, Seruseputo, Zeruborafu, Zeroda, Taruseba, Tecentoriku, Pajeta and other products. The products are mainly applied to the treatment of cancer, kidney diseases, kidney transplantation, bone and joint diseases such as rheumatoid arthritis, osteoporosis, knee osteoarthritis and locomotive syndrome, influenza, hemophilia and other diseases. The Company is also engaged in the provision of management services, transportation and storage services, as well as drug information literature research services. The Company operates within the domestic market and to overseas markets, including Switzerland, United Kingdom, Germany, France, China, Singapore, Korea and the United States.
Employees
5,104
Date Price Change Volume
26-08-13 US$22.42 -0.88% 110,264
26-08-12 US$22.62 +1.85% 177,691
26-08-11 US$22.21 -0.05% 133,358
26-08-10 US$22.22 +2.59% 418,992
26-08-07 US$21.66 +2.95% 321,899
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
7,175.00JPY
Average target price
9,426.67JPY
Spread / Average Target
+31.38%

Quarterly revenue - Rate of surprise